Expanding the spectrum of low‐grade sinonasal adenocarcinoma with biphasic seromucinous differentiation and activating HRAS/AKT1 mutations

Author:

Hadnagy Viktoria S12ORCID,Körner Meike3,Rössle Matthias4,Dubach Patrick5,Pabst Gunther6,Kotulova Alexandra7,Weder Stefan8,Seifert Robert9,Rushing Elisabeth J410,Holzmann David11,Hüllner Martin12,Freiberger Sandra N12,Rupp Niels J12ORCID

Affiliation:

1. Department of Pathology and Molecular Pathology University Hospital Zurich Zurich Switzerland

2. Faculty of Medicine University of Zurich Zurich Switzerland

3. Pathologie Laenggasse Ittigen Switzerland

4. Institute of Pathology, Lucerne Cantonal Hospital Lucerne Switzerland

5. ENT Department, Buergerspital Solothurn Solothurn Switzerland

6. Division of Otorhinolaryngology—Head and Neck Surgery Lucerne Cantonal Hospital Lucerne Switzerland

7. Institute of Tissue Medicine and Pathology, University of Bern Bern Switzerland

8. Department of Otorhinolaryngology, Head and Neck Surgery, Inselspital Bern University Hospital, University of Bern Bern Switzerland

9. Department of Nuclear Medicine Inselspital University Hospital Bern Bern Switzerland

10. Medica Laboratory Zurich Zurich Switzerland

11. Department of Otorhinolaryngology, Head and Neck Surgery University Hospital Zurich Zurich Switzerland

12. Department of Nuclear Medicine University Hospital Zurich/University of Zurich Zurich Switzerland

Abstract

AimsLow‐grade non‐intestinal‐type sinonasal adenocarcinoma (LGSNAC) is a rare heterogeneous and poorly characterised group of tumours, distinct from intestinal‐ and salivary‐type neoplasms. Therefore, further characterisation is needed for clearer biological understanding and classification.Methods and resultsClinical, histological and molecular characterisation of four cases of biphasic, low‐grade adenocarcinomas of the sinonasal tract was performed. All patients were male, aged between 48 and 78 years, who presented with polypoid masses in the nasal cavity. Microscopically, virtually all tumours were dominated by tubulo‐glandular biphasic patterns, microcystic, focal (micro)papillary, oncocytic or basaloid features. Immunohistochemical staining confirmed biphasic differentiation with an outer layer of myoepithelial cells. Molecular profiling revealed HRAS (p.G13R, p.Q61R) mutations, and concomitant AKT1 (p.E17K, p.Q79R) mutations in two cases. Two cases showed potential in‐situ/precursor lesions adjacent to the tumour. Follow‐up periods ranged from 1 to 30 months, with one case relapsing locally after 12 and > 20 years.ConclusionThis study further corroborates a distinct biphasic low‐grade neoplasm of the sinonasal tract with seromucinous differentiation. Although morphological and molecular features overlap with salivary gland epithelial–myoepithelial carcinoma, several arguments favour categorising these tumours within the spectrum of LGSNAC.

Publisher

Wiley

Reference23 articles.

1. Who classification of tumours editorial board.Head and neck tumours [internet; beta version ahead of print].Lyon (France):International Agency for Research on Cancer 2022[cited 2024 03 09]. (WHO classification of tumours series 5th ed.; vol. 9). Available from:https://tumourclassification.iarc.who.int/chapters/52.

2. Low‐grade non‐intestinal‐type sinonasal adenocarcinoma: a histologically distinctive but molecularly heterogeneous entity;Rooper LM;Mod. Pathol.,2022

3. Two cases of sinonasal non‐intestinal‐type adenocarcinoma with squamoid morules expressing nuclear beta‐catenin and cdx2: a curious morphologic finding supported by molecular analysis;Villatoro TM;Case Rep. Pathol.,2018

4. Etv6 gene rearrangements characterize a morphologically distinct subset of sinonasal low‐grade non‐intestinal‐type adenocarcinoma: a novel translocation‐associated carcinoma restricted to the sinonasal tract;Andreasen S;Am. J. Surg. Pathol.,2017

5. Combinational expression of tumor testis antigens ny‐eso‐1, mage‐a3, and mage‐a4 predicts response to immunotherapy in mucosal melanoma patients;Freiberger SN;J. Cancer Res. Clin. Oncol.,2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3